Reliv: The Nutritional Epigenetics Company
- Lunasin is the first nutritonal compound identified to affect gene expression and promote optimal health at the epigenetic level.
- LunaRich® from Reliv optimises bioactive lunasin more than any other source available today.
- Reliv owns exclusive rights to LunaRich and the lunasin technology used to create it.
LunaRich elevates Reliv to a unique status in the nutrition industry. Reliv now owns an ingredient in its entirety, from the extraction process to the patented mechanisms of action within the body. And LunaRich isn’t just any ingredient; it’s the world’s first epigenetic superfood.
Reliv has always endeavoured to remain on the cutting edge of nutrition science in formulating products. With the acquisition of lunasin, Reliv is now leading the industry in the budding field of nutritional epigenetics. New research shows that through nutrition people can influence which genes are expressed. Reliv is committed to building on this emerging science and developing nutritional solutions with lunasin and other plant-based nutrients that help people take control of their health.